The industrial base of contractors in industry seeking to do business with the National Security Agency has mushroomed in recent years, according to an NSA acquisition official.
In 2001, only 140 contractors were eligible to compete for NSA contracts. Today, there are six thousand such contractors, said Deborah Walker of the NSA. She spoke at a contractor conference sponsored by the Defense Intelligence Agency last month.
The number of contractor facilities cleared by the NSA has grown from 41 in 2002 to 1265 in 2006, according to a chart that she presented in her talk (pdf).
The result is an increase in competitiveness and improved communication with industry, Ms. Walker indicated. “Partnerships with industry [are] vital to mission success,” she said.
See “Acquisition Resource Center,” presentation by Deborah Walker, National Security Agency, May 2007, Unclassified/FOUO.
Contractors now consume as much as 70% of U.S. intelligence spending, reported Tim Shorrock in Salon last week.
See, relatedly, “Senators Fault IC on Use of Contractors” by Laura Heaton, United Press International, June 6.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.